Autor: "Fang, F." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes.
Autorzy:: Chérouvrier Hansson V; Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, SE-221 84 Lund, Sweden.
Cheng F; Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, SE-221 84 Lund, Sweden.
Georgolopoulos G; Genevia Technologies Oy, 33100 Tampere, Finland.
Mani K; Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, SE-221 84 Lund, Sweden.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 02; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Adenocarcinoma*
Humans ; Glypicans/genetics ; Oncogenes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma.
Autorzy:: Xie L; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Kong H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yu J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Thoracic Surgery, Shanghai Geriatric Medical Center, Shanghai, China.
Sun M; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Lu S; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hu J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Du F; Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lian Q; Gurdon Institute, University of Cambridge, Cambridge, UK.
Xin H; Global Institute of Future Technology, Shanghai Jiao Tong University, Shanghai, China.
Zhou J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Wang X; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institute of Clinical Bioinformatics, Shanghai, China.; Shanghai Engineering Research for AI Technology for Cardiopulmonary Diseases, Fudan University Shanghai Medical College, Shanghai, China.
Powell CA; Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hirsch FR; Tisch Cancer Institute, Center for Thoracic Oncology, Mount Sinai Health System, New York, New York, USA.
Bai C; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Song Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Yin J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang D; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1573.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lung Neoplasms*/metabolism
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Humans ; B7-H1 Antigen/genetics ; Endothelial Cells/metabolism ; Gene Expression Profiling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Autorzy:: Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang Z; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, China.
Yang F; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cao B; Department of Medical Oncology and Radiation Sickness, Cancer Center, Peking University Third Hospital, Beijing, China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Duan J; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hu J; Shanghai Geriatric Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Jin S; National Cancer Center/National Clinical Research Cencer for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, China.
Yutao L; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
Liu Z; Department of Thoracic Oncology, Jiangxi Cancer Hospital, Nanchang, China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Ma Z; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Peng M; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Tian P; Precision Medicine Key Laboratory of Sichuan Province, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang H; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Wang Y; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhang H; Department of Oncology, Guangdong Provicial Hospital of Chinese Medicine, Guangzhou, China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Zhang B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhong Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 419-426. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Consensus ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
Autorzy:: Zhou Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhang B; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Deng Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Deng S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wei W; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wang Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wang J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Feng Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Che M; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Yang X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Meng J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Hu Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Sun Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wen L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Huang F; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Sheng Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wan C; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China. .; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .
Yang K; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China. .; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jan 29; Vol. 43 (1), pp. 34. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Journal Article
MeSH Terms:: Large Neutral Amino Acid-Transporter 1*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
F-Box-WD Repeat-Containing Protein 7*/genetics
RNA-Binding Proteins*/genetics
Animals ; Mice ; Cell Line, Tumor ; Glycogen Synthase Kinase 3 beta/genetics ; RNA ; Radiation Tolerance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.
Autorzy:: Zhou F; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang M; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang Z; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Li W; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Lu X; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 28. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Humans ; mRNA Vaccines ; NLR Family, Pyrin Domain-Containing 3 Protein ; Pyroptosis/genetics ; DNA Copy Number Variations ; Phenotype ; Antigens, Neoplasm/genetics ; Prognosis ; Tumor Microenvironment ; Neoplasm Proteins ; CARD Signaling Adaptor Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study.
Autorzy:: Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wu L; The Second Department of Thoracic Oncology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Zhao J; Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Sun J; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Zhejiang, China.
Zhou J; School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shen Y; Department of Respiratory Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Chen L; Department of Oncology, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, China.
Huang M; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Lin X; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China.
Liu Z; Department of Medical Oncology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wang Z; Medical Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China.
Wang X; Department of Oncology, Zhongshan Hospital of Xiamen University, Xiamen, China.
Wang H; Department of Respiratory Medicine, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Han Z; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang H; Department of Oncology, Xijing Hospital, Airforce Military Medical University, Xian, Shanxi, China.
Ye F; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Gao W; Department of Medical Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Song Z; Department of Clinical Trial, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Chen S; Department of Oncology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China.
Zhou C; Respiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing, Nanjing, Jiangsu, China.
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wu S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
Yang S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Li Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chen S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. .; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China. .; Interdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Dec 16; Vol. 23 (1), pp. 1244. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; C-Reactive Protein ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis.
Autorzy:: Wang B; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Zou F; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Xin G; Department of Neurology Physician, First Affiliated Hospital of Hebei Northern College, Zhangjiakou, Hebei Province, P.R. China.
Xiang BL; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Zhao JQ; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Yuan SF; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Zhang XL; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.
Zhang ZH; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Hebei Northern University, Zhangjiakou, Hebei Province, P.R. China.; Pokaż więcej
Źródło:: Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 868-877.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Carcinogenesis/genetics ; Sodium ; Cell Proliferation ; Cell Movement ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Autorzy:: Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, People's Republic of China.
Wang Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yang F; Department of Thoracic Surgery, Peking University People Hospital, Beijing, People's Republic of China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Cao B; Cancer center, Peking University Third Hospital/ Department of medical oncology and radiation sickness, Peking University Third Hospital, Beijing, People's Republic of China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, People's Republic of China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Duan J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, People's Republic of China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, People's Republic of China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Hu J; Zhongshan Hospital, Fudan University, Shanghai Geriatric Center, Shanghai, People's Republic of China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Jin S; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, People's Republic of China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, People's Republic of China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, People's Republic of China.
Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China.
Liu Z; Department of Thoracic Oncology，Jiangxi Cancer Hospital, Nanchang, People's Republic of China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, People's Republic of China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Ma Z; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Peng M; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, People's Republic of China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, People's Republic of China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Tian P; Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Precision Medicine Key Laboratory of Sichuan Province, Chengdu, People's Republic of China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Wang H; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, People's Republic of China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Zhang H; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, People's Republic of China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhang B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhong F; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (34), pp. 3421-3429. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Humans ; Immunotherapy/methods ; Neoadjuvant Therapy ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis.
Autorzy:: Lu T; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Wang Y; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Liu F; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Zhang L; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Huang S; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Zhou Y; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Wu H; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Mao Y; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Jin C; Key Laboratory of Neutronics and Radiation Safety, Chinese Academy of Sciences, Hefei 230031, China.; International Academy of Neutron Science, Qingdao 266199, China.
Song W; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Nov 27; Vol. 28 (23). Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Berberine*/pharmacology
Berberine*/therapeutic use
Lung Neoplasms*/pathology
Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphatidylinositol 3-Kinase/metabolism ; Reactive Oxygen Species/pharmacology ; Temperature ; Cell Line, Tumor ; Cell Proliferation ; Signal Transduction ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.
Autorzy:: Pu X; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Central South University, Changsha, People's Republic of China.
Xu C; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China.; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Wang W; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Cai X; Department of VIP Inpatient, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Song Z; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Yu J; Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Wang Z; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zhang Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Liu J; Department of Thoracic Cancer, Jilin Cancer Hospital, Jilin, People's Republic of China.
Zhang S; Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Liu A; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Li W; Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China.
Zhan P; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Liu H; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Miao L; Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Min L; Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, People's Republic of China.
Lin G; Department of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Huang L; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Yuan J; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Jiang Z; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Rao C; Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.
Lv D; Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People's Republic of China.
Yu Z; Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, People's Republic of China.
Li X; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Tang C; Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
Zhou C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease; Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.
Zhang J; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Meng R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Liu X; Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Wu J; Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, People's Republic of China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Pan W; Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, People's Republic of China.
Pang F; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Huang J; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Wang K; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Wu F; Department of Medical, Menarini Silicon Biosystems Spa, Shanghai, People's Republic of China.
Shen T; Department of Medical, Stone Pharmaceuticals (Suzhou) Co., Ltd., Shanghai, People's Republic of China.
Zou S; Department of Medical, Stone Pharmaceuticals (Suzhou) Co., Ltd., Shanghai, People's Republic of China.
Xu B; Department of Biotherapy, Cancer Institute, First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Wang L; Department of Oncology, Baotou Cancer Hospital, Baotou, People's Republic of China.
Zhu Y; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Lin X; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease; Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.
Cai J; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu L; Department of Interventional Pulmonary Diseases, Anhui Chest Hospital, Hefei, People's Republic of China.
Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinnan, People's Republic of China.
Jiao X; Department of Medical Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Li K; Department of Oncology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Feng H; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Wang L; Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Du Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Yao W; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Shi X; Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
Niu X; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Yuan D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yao Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Kang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Zhang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Zhang C; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Fu J; Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, People's Republic of China.
Huang J; Department of Oncology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Zhang Y; Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Sun P; Department of Pathology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Wang H; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Ye M; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang Z; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Hao Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Wang Z; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing, Nanjing, People's Republic of China.
Wan B; Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Lv D; Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, People's Republic of China.
Lan G; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Yang S; Department of Thoracic Surgery, Chuxiong Yi Autonomous Prefecture People's Hospital, Chuxiong, People's Republic of China.
Shi L; Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Wang Y; Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Li B; Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Zhang Z; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Li Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Liu Z; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Wang H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Huang W; Department of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China.
Hong Z; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, People's Republic of China.
Wang G; Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Wang J; Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Fang M; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Zhu X; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing, Nanjing, People's Republic of China.
Shen Y; Department of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Zhang Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Ma S; Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Lu Y; Department of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Li Z; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Wu L; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Central South University, Changsha, People's Republic of China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (31), pp. 3166-3177. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; In Situ Hybridization, Fluorescence ; Consensus ; Proto-Oncogene Proteins c-ret/genetics ; Gene Fusion

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden.
Autorzy:: Hardardottir H; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Department of Respiratory Medicine, Landspitali University Hospital, Reykjavik, Iceland.
Aspelund T; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Fall K; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Broström E; Department of Immunology, Genetics and Pathology, Clinical and Experimental Pathology, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Sigurdsson BB; Department of Clinical Chemistry, Landspitali University Hospital, Reykjavik, Iceland.
Cook E; Department of Clinical Chemistry, Landspitali University Hospital, Reykjavik, Iceland.
Valdimarsdottir H; Department of Psychology, Reykjavik University, Reykjavik, Iceland.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
Fang F; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sloan EK; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Lutgendorf SK; Department of Psychological and Brain Sciences, University of Iowa, Iowa City, Iowa, USA.
Jansson C; Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Valdimarsdottir UA; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Oct; Vol. 62 (10), pp. 1338-1347. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnosis
Humans ; Aged ; Prospective Studies ; Iceland ; Sweden ; Anxiety/psychology ; Stress, Psychological/diagnosis ; Norepinephrine ; Depression/psychology ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study.
Autorzy:: Jia Z; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China.
Fang F; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China.
Cao Y; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China.
Zhu X; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China.
Yang X; Department of hepatic surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, 255 Changhai Road, Shanghai, 200433, China.
Guo X; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China.
Zhang H; Department of Radiation Oncology, Shanghai Changhai Hospital Affiliated to Navy Medical University, 168 Changhai Road, Shanghai, 200433, China. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2023 Aug 24; Vol. 18 (1), pp. 140. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/radiotherapy
Radiosurgery*/adverse effects
Lung Neoplasms*/radiotherapy
Humans ; Retrospective Studies ; Chemoradiotherapy/adverse effects ; Disease Progression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma.
Autorzy:: Zhang Q; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li J; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Chen Z; Department of Medical Genetics, Basic School of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Jiang K; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Yang K; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Huang F; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Huang A; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhang X; Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
Zhang J; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .
Wang H; Department of Medical Genetics, Basic School of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Pokaż więcej
Źródło:: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Aug; Vol. 46 (4), pp. 1001-1014. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/pathology
Mice ; Animals ; Female ; Humans ; Mice, Nude ; Cell Line, Tumor ; Deubiquitinating Enzymes/metabolism ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Muscle Proteins/metabolism ; Intracellular Signaling Peptides and Proteins/metabolism ; LIM Domain Proteins/metabolism ; Ubiquitin-Specific Proteases/genetics ; Ubiquitin-Specific Proteases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Autorzy:: Ma X; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Zhang K; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Xu J; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Gao H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Yang S; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Qin H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Wang H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Gao F; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Liu X; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (20), pp. 1980-1990. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Circulating Tumor DNA*/genetics
Humans ; Anaplastic Lymphoma Kinase/genetics ; Drug Resistance, Neoplasm/genetics ; Lactams, Macrocyclic/adverse effects ; Protein Kinase Inhibitors/pharmacology ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Single-Droplet Microsensor for Ultra-Short Circulating EFGR Mutation Detection in Lung Cancer Based on Multiplex EFIRM Liquid Biopsy.
Autorzy:: Wei F; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Yu P; Department of Physics, University of California, Los Angeles, CA 90095, USA.
Cheng J; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Li F; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Chia D; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Wong DTW; School of Dentistry, University of California, Los Angeles, CA 90095, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 20; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors ; Liquid Biopsy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Correlation between KRAS mutation subtypes and prognosis in Chinese advanced non-squamous non-small cell lung cancer patients.
Autorzy:: Liu F; The Third Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Zhuang Autonomous Region, China.
Wang F; Guangxi Qianhai Life Hospital, Nanning City, Guangxi Zhuang Autonomous Region, China.
He J; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning City, China.
Zhou S; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning City, China.
Luo M; The Third Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Zhuang Autonomous Region, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13123-13134. Date of Electronic Publication: 2023 May 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Proto-Oncogene Proteins p21(ras)*/genetics
Humans ; Disease Progression ; East Asian People ; Mutation ; Neoplasm Staging ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Real-world comprehensive diagnosis and "Surgery + X" treatment strategy of early-stage synchronous multiple primary lung cancer.
Autorzy:: Zhou D; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Yao T; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Huang X; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.
Wu F; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.
Jiang Y; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.
Peng M; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Qian B; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Liu W; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Yu F; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.
Chen C; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, P.R. China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 12996-13006. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Neoplasms, Multiple Primary*/genetics
Neoplasms, Multiple Primary*/surgery
Carcinoma, Non-Small-Cell Lung*/diagnosis
Humans ; Cohort Studies ; Neoplasm Recurrence, Local

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring.
Autorzy:: Liu C; Roche Tissue Diagnostics, 1910 E. Innovation Park Dr., Oro Valley, Tucson, AZ, 85755, USA.
Fang F; Roche Tissue Diagnostics, 1910 E. Innovation Park Dr., Oro Valley, Tucson, AZ, 85755, USA.
Kong Y; Roche Tissue Diagnostics, 1910 E. Innovation Park Dr., Oro Valley, Tucson, AZ, 85755, USA. .
ElGabry EA; Roche Tissue Diagnostics, 1910 E. Innovation Park Dr., Oro Valley, Tucson, AZ, 85755, USA.; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2023 Apr 19; Vol. 18 (1), pp. 48. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*/metabolism
Lung Neoplasms*/pathology
Humans ; Immunohistochemistry ; Reproducibility of Results ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study.
Autorzy:: Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wang Q; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Liu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Chen B; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Li K; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Zhou Y; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Sheng Z; Department of Oncology, The Third Hospital of Changsha, Changsha, China.
Liu P; Department of Respiratory, The First Hospital of Changsha, Changsha, China.
Tang Y; Department of Oncology, Hengyang Central Hospital/the affiliated Hengyang Hospital of Southern Medical University, Hengyang, China.
Xu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Li J; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Kong Y; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xu F; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xu Y; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 7724-7733. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Adenocarcinoma*/drug therapy
Humans ; Endostatins/adverse effects ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Angiogenesis Inhibitors/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Potential of artificial intelligence based on chest computed tomography to predict the nature of part-solid nodules.
Autorzy:: Ke X; Department of CT/MRI, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Hu W; Department of CT/MRI, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Su X; Department of CT/MRI, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Huang F; Department of CT/MRI, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Lai Q; Department of CT/MRI, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.; Pokaż więcej
Źródło:: The clinical respiratory journal [Clin Respir J] 2023 Apr; Vol. 17 (4), pp. 320-328. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Artificial Intelligence*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; ROC Curve

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Fang, F."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język